Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk

Schizophrenia Bulletin

Volumn 33, Issue 3, 2007, Pages 682-687

  Morrison, Anthony P ^a,b   French, Paul ^a   Parker, Sophie ^a   Roberts, Morwenna ^a   Stevens, Helen ^a   Bentall, Richard P ^b   Lewis, Shôn W ^b  

^a GREATER MANCHESTER MENTAL HEALTH NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Cognitive therapy; Early intervention; Prevention; Psychosis

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; INTERMETHOD COMPARISON; MALE; PATIENT MONITORING; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; EARLY DIAGNOSIS; OUTCOME ASSESSMENT; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; REGRESSION ANALYSIS; RISK; SCHIZOPHRENIA; SCHIZOTYPAL PERSONALITY DISORDER; SINGLE BLIND PROCEDURE; STATISTICAL MODEL; UNITED KINGDOM;

NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; COGNITIVE THERAPY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EARLY DIAGNOSIS; ENGLAND; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIKELIHOOD FUNCTIONS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; REGRESSION ANALYSIS; RISK; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SCHIZOTYPAL PERSONALITY DISORDER; SINGLE-BLIND METHOD;

EID: 34548048405     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbl042     Document Type: Article

References (15)

1. Yung A, McGorry PD, McFarlane CA, Jackson H, Patton GC, Rakkar A. Monitoring and care of young people at incipient risk of psychosis. Schizophr Bull. 1996;22:283-303.
2. McGorry PD, Yung AR, Phillips LJ, et al. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry. 2002;59:921-928.
3. Morrison AP, French P, Walford L, et al. Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. Br J Psychiatry. 2004;185:291-297.
4. Kay SR, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:507-518.
5. Goldberg DP, Hillier VF. A scaled version of the general health questionnaire. Psychol Med. 1979;9:139-145.
6. American Psychiatric Association.Diagnostic and Statistical Manual for Mental Disorders. 4th ed Washington, DC: American Psychiatric Association; 1994.
7. Cartwright Hatton S, Wells A. Beliefs about worry and intrusions: the Meta-Cognitions Questionnaire and its correlates. J Anxiety Disord. 1997;11:279-296.
8. Bieling PJ, Beck AT, Brown GK. The Sociotropy-Autonomy Scale: structure and implications. Cognit Ther Res. 2000;24:763-780.
9. French P, Morrison AP. Early Detection and Cognitive Therapy for People at High Risk of Developing Psychosis: A Treatment Approach. London, England: Wiley; 2004.
10. Morrison AP. The interpretation of intrusions in psychosis: an integrative cognitive approach to hallucinations and delusions. Behav Cogn Psychother. 2001;29:257-276.
11. Morrison AP, French P, Lewis SW, et al. Psychological factors in people at ultra-high risk of psychosis: comparisons with non-patients and associations with symptoms. Psychol Med. In press.
12. McGorry PD, Mihalopoulos C, Henry L, et al. Spurious precision: procedural validity of diagnostic assessment in psychotic disorders. Am J Psychiatry. 1995;152:220-223.
13. McGlashan TH, Zipursky RB, Perkins D, et al. Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry. 2006;163:790-799.
14. Addington J, Addington D. Clinical trials during the prodromal stage of schizophrenia. Am J Psychiatry. 2005;162:1387.
15. Bentall RP, Morrison AP. More harm than good: the case against using antipsychotic drugs to prevent severe mental illness. J Ment Health. 2002;11:351-365.